Back from an incredible week at #KetamineConference2024 with Oxford Psychiatry ! It was a pleasure to speak and learn about all the ways this field is growing.

We are thrilled to announce that Dr. Albert Garcia-Romeu (AlChemical77) has been appointed as Associate Director of the CPCR and the Susan Hill Ward Professor in Psychedelics and Consciousness. Dr. Garcia-Romeu is a respected and beloved colleague both in the CPCR and the…

I enjoyed contributing to this article by
Shayla Love for Psyche Magazine ! Shayla dives into 'dissociation' with ketamine and as a construct in psychiatry, inviting us into a broader story about what it means to disrupt ordinary consciousness psyche.co/ideas/the-ther…

‘When a person takes ketamine, time can slow down. Their perception of their body might start to shift.’ In ketamine therapy and other contexts, dissociation is seen as an unwanted side-effect. But is there therapeutic potential to losing yourself? bit.ly/3SSYf8q

We talk a lot about the subjective effects of drugs like psilocybin. Yet for ketamine, dissociation can be viewed as just a side effect. For Psyche Magazine I wrote about a broader consideration of what dissociation feels like and what it means to people.
psyche.co/ideas/the-ther…

Grateful to be featured by PsyPost.org for our comparison of #psilocybin and #dextromethorphan ! We focused here on subjective drug experiences and psychological benefits that have been minimally explored for #dissociative therapies like dextromethorphan and #ketamine .

MAPS PBC announces submission of a new drug application to the U.S. FDA for MDMA-assisted therapy for PTSD. Read the full announcement here: bit.ly/46RMtQt #PTSD #mentalhealth

What could mental health recovery look like in the future given the surge of interest in #psychedelic drugs? I'm delighted to share my recent conversation with Menninger clinicians Dr. Bob Boland and Dr. Kerry Horrell at #MindDive podcast: buzzsprout.com/1924542/139867…

We are less than 2 weeks away! Learn about the future of wellness from November 9-11 at Wonderland Conference Miami. If you're interested in attending this event, please save 20% by using the discount code DAVIDM20 at checkout, or clicking this link: bit.ly/3MiXovj

Beautifully put David B. Yaden - I'm thankful to have known Roland and for his incredible legacy.

Congrats Boris D Heifets et al!

Thanks Jules Evans for this fascinating take on our work! Would recommend for anyone looking to better understand psychedelic shame/guilt narratives and moral histories that can contribute.

New paper on feelings of shame and guilt during psilocybin experiences by David Mathai, MD et al. We see it in our data too - people can feel they have failed a test, committed some awful crime or broken a taboo and will be scapegoated, cursed or punished. osf.io/preprints/psya…

We are recruiting for our most recent psilocybin smoking cessation study in Baltimore! Please repost! If interested, you can initiate screening through the website below.
quitsmokingbaltimore.org

Actively recruiting licensed clinicians for our #psychedelics and #gender study - contact me or Dr Dr Pani Farvid to participate, and spread the word! #psychedelicresearch #gender dysphoria #sexuality #SexTechLab

Thrilled to see the interest in our Johns Hopkins Psychedelic Research Center project!

This prospective longitudinal study (n=2,833) examined naturalistic psilocybin use among adults outside of clinical research settings. buff.ly/45faOz7

Johns Hopkins Psychedelic Research Center Sandeep Nayak Nate Sepeda David Mathai, MD Fred Barrett Justin Strickland Matthew W. Johnson We're humbled to be part of this collective and know this data will advance our understanding of real world use in meaningful ways.